NovaGo Therapeutics AG, based in Switzerland

NovaGo Therapeutics is a biotech startup company dedicated to the development of biopharmaceutical products that promote nerve repair and regeneration on the treatment of diseases of the central nervous system. NovaGo's management and Board of Directors team comprises experienced industry professionals and researchers with a proven track record in translational research and drug development. Existing international collaborations and networks with partners in industry, academia, and the medical community leverage the advancement of NovaGo's programs.